We are live on ! Find out more
EAM

Erste Asset Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 52.69%
This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+52.69%
3 Year Est. Return
+142.55%
5 Year Est. Return
+182.36%
10 Year Est. Return
AUM
$4.74B
AUM Growth
+$276M
Cap. Flow
-$5.22M
Cap. Flow %
-0.11%
Top 10 Hldgs %
17.82%
Holding
617
New
57
Increased
184
Reduced
143
Closed
49

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Healthcare 20.98%
3 Consumer Discretionary 11.7%
4 Financials 9.74%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDS icon
476
GDS Holdings
GDS
$6.1B
$252K 0.01%
12,000
-151,999
-93% -$2.33M
OWL icon
477
Blue Owl Capital
OWL
$7B
$249K 0.01%
23,460
RNAM
478
DELISTED
Avidity Biosciences
RNAM
$247K 0.01%
10,900
IMGN
479
DELISTED
Immunogen Inc
IMGN
$243K 0.01%
47,000
RNG icon
480
RingCentral
RNG
$6.05B
$243K 0.01%
+7,300
New +$261K
CINF icon
481
Cincinnati Financial
CINF
$26.3B
$240K 0.01%
2,300
-1,400
-38% -$144K
EG icon
482
Everest Group
EG
$14.6B
$234K ﹤0.01%
700
-500
-42% -$156K
GRFS
483
Grifois
GRFS
$5.01B
$231K ﹤0.01%
27,056
CMRX
484
DELISTED
Chimerix, Inc.
CMRX
$226K ﹤0.01%
121,000
MORF
485
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$225K ﹤0.01%
8,500
KZR
486
DELISTED
Kezar Life Sciences
KZR
$218K ﹤0.01%
3,100
IOVA icon
487
Iovance Biotherapeutics
IOVA
$4.24B
$213K ﹤0.01%
34,000
VERV
488
DELISTED
Verve Therapeutics
VERV
$213K ﹤0.01%
11,300
INBX
489
DELISTED
Inhibrx, Inc. Common Stock
INBX
$209K ﹤0.01%
8,700
AEL
490
DELISTED
American Equity Investment Life Holding Company
AEL
$198K ﹤0.01%
+4,300
New +$173K
PVH icon
491
PVH
PVH
$3.3B
$192K ﹤0.01%
2,710
ALLO icon
492
Allogene Therapeutics
ALLO
$594M
$187K ﹤0.01%
31,400
ESGR
493
DELISTED
Enstar Group
ESGR
$185K ﹤0.01%
+800
New +$163K
ZNTL icon
494
Zentalis Pharmaceuticals
ZNTL
$296M
$180K ﹤0.01%
9,800
ALEC icon
495
Alector
ALEC
$228M
$180K ﹤0.01%
19,000
LYEL icon
496
Lyell Immunopharma
LYEL
$267M
$178K ﹤0.01%
2,700
WRB icon
497
W.R. Berkley
WRB
$26.5B
$176K ﹤0.01%
3,600
-5,700
-61% -$275K
CRVL icon
498
CorVel
CRVL
$3.62B
$175K ﹤0.01%
+3,600
New +$179K
RLI icon
499
RLI Corp
RLI
$5.63B
$174K ﹤0.01%
+2,600
New +$162K
ESNT icon
500
Essent Group
ESNT
$6.13B
$173K ﹤0.01%
+4,400
New +$167K

Similar funds

Erste Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Erste Asset Management held 617 positions worth $4.74B, up 6.2% from $4.46B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Erste Asset Management's Q4 2022 filing shows 57 new, 184 increased, 143 reduced and 49 closed positions. Its largest new stake was Kinsale Capital Group: 38,600 shares worth $10.1M. The largest sale was Daqo New Energy, an estimated $22.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Erste Asset Management's largest Q4 2022 buy was Kinsale Capital Group: 38,600 shares worth $10.1M.
  • Erste Asset Management added most to Alphabet (Google) Class A in Q4 2022, an estimated $11.2M increase.
  • Erste Asset Management's biggest Q4 2022 reduction was Daqo New Energy, cutting an estimated $22.9M.
  • Erste Asset Management fully exited Diageo in Q4 2022, selling an estimated $7.53M.
  • Erste Asset Management's ten largest holdings make up 18% of its $4.74B portfolio in Q4 2022.
  • Erste Asset Management opened 57 new positions and closed 49 in Q4 2022.
  • Erste Asset Management's portfolio value rose 6.2% quarter-over-quarter to $4.74B.

Based on Erste Asset Management's 13F filing for Q4 2022, filed 26 Nov 2024.